Connexis Blog Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products

For Immediate Release December 6, 2018 Release One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled. When an in vitro diagnostic test gets approved, it's often based on the results of studies with one specific Read MoreThe post Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products appeared first on Connexis Search Group.